$33 million announced to advance technology innovations in Alberta’s agriculture, agri-food, and forestry sectors

$33 million announced to advance technology innovations in Alberta’s agriculture, agri-food, and forestry sectors
  EDMONTON – Using drones to help reforest remote boreal environments. Reducing methane emissions from cattle by up to 90 per cent through feed additives. Leveraging artificial intelligence to optimize energy usage at a pulp mill. These are three of 17 technology innovations that will receive funding from the Government of Alberta through Emissions Reduction Alberta (ERA). Alberta’s Minister of... Read More

$25 million to support technology and business accelerators in Alberta

$25 million to support technology and business accelerators in Alberta
EDMONTON – Alberta Innovates is issuing a request for proposals for the development of business accelerators to vault Alberta’s promising start-ups and small and medium technology companies through scaleup and growth faster. Alberta has a scaleup gap. While half of all start-ups survive over five years, only 0.1 per cent of small firms become mid-sized, and only two per cent... Read More

Silo Wellness begins trading on the CSE under ticker symbol “SILO”

Silo Wellness begins trading on the CSE under ticker symbol “SILO”
TORONTO – SILO WELLNESS INC. (CSE: SILO), announced that trading its common shares on the Canadian Securities Exchange will commence today under the ticker symbol “SILO”. “We are delighted to be trading on the CSE as the next step in Silo Wellness’ journey in the functional mushroom and psychedelics marketplaces and celebrate this important milestone with the team who have... Read More

BetterLife engages Eurofins CDMO for psychedelic TD-0148A manufacturing

BetterLife engages Eurofins CDMO for psychedelic TD-0148A manufacturing
  VANCOUVER – BetterLife Pharma Inc. (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental disorders and viral infections, announces it has entered into an agreement with Eurofins CDMO Alphora Inc.  for TD-0148A’s GMP manufacturing. BetterLife’s TD-0148A is a second-generation lysergic acid diethylamide (“LSD”) derivative molecule, 2-bromo-LSD, that BetterLife believes will... Read More

The hidden costs of feel-good stocks

The hidden costs of feel-good stocks
  WINNIPEG – The stakeholder-shareholder debate in finance has narrowed down to a false dichotomy between good capitalism and bad capitalism. Good capitalism means funding green energy to fight global warming, while bad capitalism means investing in fossil fuels, tobacco, or other “sin stocks.” However, the economic downturn should be a wake-up call to investors regarding the hidden costs of... Read More

US companies raised $145.3B through IPOs in 2020, the highest value in twenty years

US companies raised $145.3B through IPOs in 2020, the highest value in twenty years
  LONDON – The year 2020 was a fantastic year for IPO investors who benefited from both the number of IPOs and their outsized average returns, despite the pandemic. In the United States, initial public offerings hit a new record. According to data presented by Stock Apps, US companies raised $145.3bn through IPOs last year, the highest value since 2000. Value... Read More

Medexus Submits Application to List on the Nasdaq

Medexus Submits Application to List on the Nasdaq
TORONTO – Medexus Pharmaceuticals Inc. (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) announced today that it has submitted its application to list on The Nasdaq Capital Market. Ken d’Entremont, Chief Executive Officer of Medexus, commented, “The submission of our application to list on the Nasdaq marks a significant milestone for Medexus. We believe we now meet the initial listing requirements, which reflects... Read More

Graphene-based sensors being developed to detect disease

Graphene-based sensors being developed to detect disease
  ADELAIDE – Based in Adelaide, South Australia, Sparc Technologies Limited has partnered with the University of Adelaide to develop non-invasive sensing devices to detect disease in humans and animals. Sparc’s new graphene biomedical division will research graphene-based sensing devices used to detect volatile organic compounds (VOCs). VOCs are understood to be indicators of disease and are present in exhaled... Read More

Relay Medical and Glow LifeTech report on successful phase II clinical results for COVID-19 treatment

Relay Medical and Glow LifeTech report on successful phase II clinical results for COVID-19 treatment
  TORONTO – Relay Medical Corp. (CSE: RELA, OTC: RYMDF, Frankfurt: EIY2), a developer of MedTech innovation, and Glow LifeTech Ltd. a private company in which Relay holds a significant equity interest, today reported on developments related to Glow’s MyCell Technology™. Glow LifeTech partner Swiss Pharmacan AG, and MGC Pharma have announced the full results of Phase II double-blind, placebo-controlled... Read More

Pure Extracts outlines study on psilocybin oral tablets, capsules and nasal gel

Pure Extracts outlines study on psilocybin oral tablets, capsules and nasal gel
VANCOUVER – Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) a plant-based extraction company, reported that it has delineated the timetable and milestones for its study on the formulation and manufacturing of psilocybin based active treatments for oral tablets, capsules and a nasal gel that will be used as an investigational product. The study with be conducted at... Read More